Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
REVENUE	$ 1,930,108	$ 1,001,252	$ 5,501,527	$ 2,197,734
Cost of Revenue	1,105,271	859,363	2,372,011	1,643,724
GROSS PROFIT	824,837	141,889	3,129,516	554,010
EXPENSES
General and administrative expenses [Notes 8, 9 and 10]	4,659,638	3,338,382	13,921,014	9,152,010
Research and development expenses	900,499	681,411	2,115,134	1,507,634
TOTAL OPERATING EXPENSES	5,560,137	4,019,793	16,036,148	10,659,644
Other (income)/expense [Note 8] [Note 9]	264,734	(8,637)	1,101,095	(25,604)
Accretion and amortization expenses [Note 5] [Note 6]	1,334,842	380,692	8,834,728	722,795
Change in fair value of derivative liabilities [Note 8]	774,773	(349,714)	676,182	(783,193)
NET LOSS BEFORE INCOME TAXES	(7,109,649)	(3,900,245)	(23,518,637)	(10,019,632)
Income taxes
NET LOSS BEFORE DIVIDENDS	(7,109,649)	(3,900,245)	(23,518,637)	(10,019,632)
Less: Preferred Stock Dividends	233,222	218,904	719,086	649,336
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	(7,342,871)	(4,119,149)	(24,237,723)	(10,668,968)
Translation adjustment	(20,064)	366,788	(1,841)	187,247
COMPREHENSIVE LOSS	$ (7,362,935)	$ (3,752,361)	$ (24,239,564)	$ (10,481,721)
LOSS PER SHARE, BASIC AND DILUTED	$ (0.149)	$ (0.111)	$ (0.554)	$ (0.288)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING	49,168,264	37,256,315	43,747,569	37,038,957